Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Warpaint London renews contract with Ward & Hagon

(Sharecast News) - Cosmetics company Warpaint London has renewed its contract with Ward & Hagon, it announced on Thursday, effective from 1 January and spanning 24 months, with an option for continued partnership under the same terms and a mutually agreed six-month notice period. The AIM-traded firm said it initially enlisted the services of Ward & Hagon, a firm specialising in practical business solutions, in February 2020.

It said the partnership aimed to assist Warpaint in executing its strategic growth plan.

Subsequently, the contract was renewed on 19 February 2021 for a 12-month period and then again on 1 March 2022, for a more extended 24-month term from 1 January 2022.

The primary objective behind the contract renewal was to sustain and accelerate Warpaint's growth trajectory and foster further business transformation.

Warpaing said the contract would encompass a total fixed value of £0.45m over 24 months, or £0.225m per annum.

This value covers the services provided by Paul Hagon, an executive director of Warpaint, and Martyn Ward, along with other members of the Ward & Hagon team.

Additionally, the contract presented an opportunity for Ward & Hagon to earn up to £0.175m per annum through non-discretionary performance-related sales bonuses and commissions.

The payments stipulated in the contract would be met from the operating cash flows of the Warpaint Group.

At 1158 GMT, shares in Warpaint London were down 0.13% at 384.5p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

ECR Minerals mulls expansion into US helium market
(Sharecast News) - ECR Minerals, an exploration and development company traditionally focused on gold in Australia, announced on Friday that its board was exploring potential investments in producing helium assets in the United States.
Zenova reports solid momentum as interim loss narrows
(Sharecast News) - Fire safety and heat management technology specialist Zenova Group reported significant first-half strides in its interim results on Friday, despite a challenging financial backdrop.
Jefferies lowers target price on Life Science REIT
(Sharecast News) - Jefferies cut its price target on real estate investment trust Life Sciences REIT from 45.0p to 36.0p following a visit to the group's Cambourne Science & Technology Park.
Beowulf reports substantial first-half progress
(Sharecast News) - Mineral explorer and developer Beowulf Mining reported substantial progress across its portfolio in its interim results on Friday, particularly in advancing its key projects at Gállok in Sweden and the Graphite Anode Materials Plant (GAMP) in Finland.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.